Transforming Medicine with Targeted Protein Degradation (TPD)

Targeted Protein Degradation (TPD) represents a groundbreaking therapeutic approach that goes beyond traditional drug development. Unlike conventional small molecule drugs that inhibit protein functions, TPD leverages the cell’s natural protein degradation machinery to selectively eliminate disease-causing proteins. By degrading disease-causing proteins through innovative approaches, TPD opens up possibilities to target previously “undruggable” proteins, revolutionizing the treatment landscape across multiple diseases.

Pioneering the Future of TPD with CellgeneTech

At CellgeneTech, we are driven by a mission to lead the next wave of innovation in the TPD field. By collaborating with world-class scientists and business experts, we are committed to advancing cutting-edge TPD products with the potential to transform lives. Through our integrated approach to research, development, and commercialization, we aim to deliver first-in-class and best-in-class therapies that redefine what’s possible in modern medicine with focus on oncology and auto immune indications. 

Together, we’re shaping a future where science and innovation converge to address unmet medical needs.